1243223

Novocol Pharmaceutical of Canada, Inc. — FEI 3002807757

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 3, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cambridge (Canada)